These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1348545)

  • 1. Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones.
    Huang Z; Vafai A; Lee J; Mahalingam R; Hayward AR
    J Virol; 1992 May; 66(5):2664-9. PubMed ID: 1348545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system.
    Yao Z; Jackson W; Forghani B; Grose C
    J Virol; 1993 Jan; 67(1):305-14. PubMed ID: 8380078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.
    Vafai A; Yang WN
    J Virol; 1991 Oct; 65(10):5593-6. PubMed ID: 1654454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype, cytotoxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes.
    Hayward A; Giller R; Levin M
    Viral Immunol; 1989; 2(3):175-84. PubMed ID: 2483504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
    Lowry PW; Solem S; Watson BN; Koropchak CM; Thackray HM; Kinchington PR; Ruyechan WT; Ling P; Hay J; Arvin AM
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells.
    Hayward AR; Pontesilli O; Herberger M; Laszlo M; Levin M
    J Virol; 1986 Apr; 58(1):179-84. PubMed ID: 3005647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription mapping of glycoprotein I (gpI) and gpIV of varicella-zoster virus and immunological analysis of the gpI produced in cells infected with the recombinant vaccinia virus.
    Kato T; Kitamura K; Hayakawa Y; Takahashi M; Kojima A; Sato S; Yamanishi K
    Microbiol Immunol; 1989; 33(4):299-312. PubMed ID: 2549343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of CD3 hybridoma targets by cloned human CD4 lymphocytes.
    Hayward A; Boylston A; Beverley P
    Immunology; 1988 May; 64(1):87-92. PubMed ID: 2454888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex).
    Yao Z; Grose C
    J Virol; 1994 Jul; 68(7):4204-11. PubMed ID: 8207795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional analysis of two simian varicella virus glycoprotein genes which are homologous to varicella-zoster virus gpI (gE) and gpIV (gI).
    Fletcher TM; Gray WL
    Virology; 1994 Nov; 205(1):352-9. PubMed ID: 7975231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
    J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI.
    Litwin V; Jackson W; Grose C
    J Virol; 1992 Jun; 66(6):3643-51. PubMed ID: 1316474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existence of similar antigenic-sites on varicella-zoster virus gpI and gpIV.
    Vafai A; Jensen K; Kubo R
    Virus Res; 1989 Aug; 13(4):319-36. PubMed ID: 2479191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of similar epitopes on varicella-zoster virus gpI and gpIV by monoclonal antibodies.
    Vafai A; Wroblewska Z; Mahalingam R; Cabirac G; Wellish M; Cisco M; Gilden D
    J Virol; 1988 Aug; 62(8):2544-51. PubMed ID: 2455814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones.
    Yakushijin Y; Yasukawa M; Kobayashi Y
    J Virol; 1992 May; 66(5):2773-9. PubMed ID: 1348547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
    Ouwendijk WJ; Geluk A; Smits SL; Getu S; Osterhaus AD; Verjans GM
    J Immunol; 2014 Apr; 192(8):3730-9. PubMed ID: 24623134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV.
    Hayward AR
    J Virol; 1990 Feb; 64(2):651-5. PubMed ID: 2153231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
    Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB
    Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones.
    Livingston PG; Kurane I; Lai CJ; Bray M; Ennis FA
    J Virol; 1994 May; 68(5):3283-8. PubMed ID: 7908702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.
    Wallace LE; Wright J; Ulaeto DO; Morgan AJ; Rickinson AB
    J Virol; 1991 Jul; 65(7):3821-8. PubMed ID: 1710291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.